Literature DB >> 18605766

Avoiding underdiagnosis, overdiagnosis, and misdiagnosis of lung carcinoma.

Kelly J Butnor1.   

Abstract

CONTEXT: Given the magnitude of the therapeutic and prognostic implications, it is critical that pathologists diagnose lung cancer accurately. This can sometimes be a formidable challenge, as a number of benign entities mimic lung carcinoma and vice versa.
OBJECTIVE: To present strategies for recognizing benign entities likely to be confused with lung carcinoma, malignancies of the lung prone to misinterpretation as benign, and commonly misclassified pulmonary neoplasms. DATA SOURCES: The medical literature and experience from consultative and surgical practice.
CONCLUSIONS: In addition to understanding the clinical context in which a lung biopsy is procured and the radiographic findings, appreciating the histologic distribution of disease and what, if any, pathologic features are present in the background can go a long way toward averting a misdiagnosis of lung cancer. Recognizing the limitations posed by small samples and communicating clearly to clinicians the level of diagnostic uncertainty are equally as important for establishing an accurate diagnosis of lung cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18605766     DOI: 10.5858/2008-132-1118-AUOAMO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Type I insulin-like growth factor receptor induces pulmonary tumorigenesis.

Authors:  Nicolle M Linnerth; Megan D Siwicky; Craig I Campbell; Katrina L M Watson; James J Petrik; Jeffrey A Whitsett; Roger A Moorehead
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

2.  Evaluation of Imprint Smears of Bronchoscopic Biopsy in Lung Tumors: A Cytohistological Correlation.

Authors:  Abhishek Chowdhury
Journal:  J Cytol       Date:  2019 Jul-Sep       Impact factor: 1.000

3.  Identification of transcriptional subtypes in lung adenocarcinoma and squamous cell carcinoma through integrative analysis of microarray and RNA sequencing data.

Authors:  François Fauteux; Anuradha Surendra; Scott McComb; Youlian Pan; Jennifer J Hill
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.996

4.  Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodules.

Authors:  Jian Zhou; Tong Cheng; Xing Li; Jie Hu; Encheng Li; Ming Ding; Rulong Shen; John P Pineda; Chun Li; Shaohua Lu; Hongyu Yu; Jiayuan Sun; Wenbin Huang; Xiaonan Wang; Han Si; Panying Shi; Jing Liu; Meijia Chang; Maosen Dou; Meng Shi; Xiaofeng Chen; Rex C Yung; Qi Wang; Ning Zhou; Chunxue Bai
Journal:  Clin Epigenetics       Date:  2021-12-14       Impact factor: 6.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.